CinCor Pharma
Ulrich Granzer is a Scientific Advisor at CinCor Pharma. He is the owner of Granzer Regulatory Consulting & Services.
This person is not in the org chart
This person is not in any offices
CinCor Pharma
CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.